81033-105 : Atovaquone Oral Suspension Oral Suspension 750 mg/5ml Oral Suspension
| NDC: | 81033-105 |
| Labeler: | Kesin Pharma Corporation |
| Product Type: | Human Prescription Drug |
| Drug Name: | Atovaquone Oral Suspension |
| Dosage Form: | Oral Suspension |
| Application #: | ANDA210510 |
| Rev. Date: |
NDC Package Codes:
- 81033-105-22: 20 CUP, UNIT‑DOSE IN 1 CARTON (81033‑105‑22) / 5 ML IN 1 CUP, UNIT‑DOSE (81033‑105‑05)
- 81033-105-42: 42 CUP, UNIT‑DOSE IN 1 CARTON (81033‑105‑42) / 5 ML IN 1 CUP, UNIT‑DOSE (81033‑105‑05)
Active Ingredients:
- Atovaquone
Dosage Strength:
- 750 mg/5mL
Pharmaceutical Classes:
- Antimalarial [EPC]
- Antiprotozoal [EPC]
Related Products:
Based on records with the same trade name.- 10702-223 Atovaquone Oral Suspension Oral Suspension 750 mg/5ml Oral Suspension by Kvk-tech, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 81033-104Next: 81033-113 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.